EUDA Health Limited (EUDA)
EUDA Health Statistics
Share Statistics
EUDA Health has 37.15M shares outstanding. The number of shares has increased by 50.86% in one year.
Shares Outstanding | 37.15M |
Shares Change (YoY) | 50.86% |
Shares Change (QoQ) | 5.77% |
Owned by Institutions (%) | n/a |
Shares Floating | 20.06M |
Failed to Deliver (FTD) Shares | 111 |
FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 8.34K, so 0.02% of the outstanding shares have been sold short.
Short Interest | 8.34K |
Short % of Shares Out | 0.02% |
Short % of Float | 0.04% |
Short Ratio (days to cover) | 0.08 |
Valuation Ratios
The PE ratio is -3.88 and the forward PE ratio is -47.88. EUDA Health's PEG ratio is 0.05.
PE Ratio | -3.88 |
Forward PE | -47.88 |
PS Ratio | 10.51 |
Forward PS | 4.1 |
PB Ratio | -5.2 |
P/FCF Ratio | -13.35 |
PEG Ratio | 0.05 |
Enterprise Valuation
EUDA Health Limited has an Enterprise Value (EV) of 23.56M.
EV / Earnings | -2.35 |
EV / Sales | 6.36 |
EV / EBITDA | -2.84 |
EV / EBIT | -5.95 |
EV / FCF | -8.07 |
Financial Position
The company has a current ratio of 0.08, with a Debt / Equity ratio of -0.45.
Current Ratio | 0.08 |
Quick Ratio | 0.08 |
Debt / Equity | -0.45 |
Total Debt / Capitalization | -81.83 |
Cash Flow / Debt | -0.86 |
Interest Coverage | -170.55 |
Financial Efficiency
Return on equity (ROE) is 1.34% and return on capital (ROIC) is 96.44%.
Return on Equity (ROE) | 1.34% |
Return on Assets (ROA) | -7.66% |
Return on Capital (ROIC) | 96.44% |
Revenue Per Employee | $34,966.58 |
Profits Per Employee | $-94,712.08 |
Employee Count | 106 |
Asset Turnover | 2.83 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 104.44% in the last 52 weeks. The beta is -0.06, so EUDA Health's price volatility has been lower than the market average.
Beta | -0.06 |
52-Week Price Change | 104.44% |
50-Day Moving Average | 3.86 |
200-Day Moving Average | 4.02 |
Relative Strength Index (RSI) | 42.51 |
Average Volume (20 Days) | 104.8K |
Income Statement
In the last 12 months, EUDA Health had revenue of 3.71M and earned -10.04M in profits. Earnings per share was -0.37.
Revenue | 3.71M |
Gross Profit | 842.08K |
Operating Income | -3.96M |
Net Income | -10.04M |
EBITDA | -8.3M |
EBIT | -3.96M |
Earnings Per Share (EPS) | -0.37 |
Balance Sheet
The company has 189K in cash and 3.37M in debt, giving a net cash position of -3.19M.
Cash & Cash Equivalents | 189K |
Total Debt | 3.37M |
Net Cash | -3.19M |
Retained Earnings | -34.74M |
Total Assets | 2.03M |
Working Capital | -6.83M |
Cash Flow
In the last 12 months, operating cash flow was -2.92M and capital expenditures -5, giving a free cash flow of -2.92M.
Operating Cash Flow | -2.92M |
Capital Expenditures | -5 |
Free Cash Flow | -2.92M |
FCF Per Share | -0.11 |
Margins
Gross margin is 22.72%, with operating and profit margins of -106.87% and -270.86%.
Gross Margin | 22.72% |
Operating Margin | -106.87% |
Pretax Margin | -227.57% |
Profit Margin | -270.86% |
EBITDA Margin | -223.94% |
EBIT Margin | -106.87% |
FCF Margin | -78.72% |
Dividends & Yields
EUDA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -10.05% |
FCF Yield | -2.13% |
Analyst Forecast
Currently there are no analyst rating for EUDA.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -36.53 |
Piotroski F-Score | 2 |